Menu
GeneBe

rs375440874

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_006950.3(SYN1):c.1325T>C(p.Leu442Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000978 in 1,186,149 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 28 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L442L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00053 ( 0 hom., 16 hem., cov: 23)
Exomes 𝑓: 0.000053 ( 0 hom. 12 hem. )

Consequence

SYN1
NM_006950.3 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.976
Variant links:
Genes affected
SYN1 (HGNC:11494): (synapsin I) This gene is a member of the synapsin gene family. Synapsins encode neuronal phosphoproteins which associate with the cytoplasmic surface of synaptic vesicles. Family members are characterized by common protein domains, and they are implicated in synaptogenesis and the modulation of neurotransmitter release, suggesting a potential role in several neuropsychiatric diseases. This member of the synapsin family plays a role in regulation of axonogenesis and synaptogenesis. The protein encoded serves as a substrate for several different protein kinases and phosphorylation may function in the regulation of this protein in the nerve terminal. Mutations in this gene may be associated with X-linked disorders with primary neuronal degeneration such as Rett syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01687032).
BP6
Variant X-47574756-A-G is Benign according to our data. Variant chrX-47574756-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 193940.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=2}.
BS2
High Hemizygotes in GnomAd at 15 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SYN1NM_006950.3 linkuse as main transcriptc.1325T>C p.Leu442Pro missense_variant 11/13 ENST00000295987.13
SYN1NM_133499.2 linkuse as main transcriptc.1325T>C p.Leu442Pro missense_variant 11/13

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SYN1ENST00000295987.13 linkuse as main transcriptc.1325T>C p.Leu442Pro missense_variant 11/132 NM_006950.3 P3P17600-1
SYN1ENST00000340666.5 linkuse as main transcriptc.1325T>C p.Leu442Pro missense_variant 11/131 A1P17600-2
SYN1ENST00000640721.1 linkuse as main transcriptc.2T>C p.Leu1Pro missense_variant 1/25

Frequencies

GnomAD3 genomes
AF:
0.000520
AC:
58
AN:
111639
Hom.:
0
Cov.:
23
AF XY:
0.000443
AC XY:
15
AN XY:
33873
show subpopulations
Gnomad AFR
AF:
0.00189
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000128
AC:
17
AN:
132407
Hom.:
0
AF XY:
0.000139
AC XY:
6
AN XY:
43099
show subpopulations
Gnomad AFR exome
AF:
0.00205
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000530
AC:
57
AN:
1074462
Hom.:
0
Cov.:
31
AF XY:
0.0000343
AC XY:
12
AN XY:
350126
show subpopulations
Gnomad4 AFR exome
AF:
0.00183
Gnomad4 AMR exome
AF:
0.0000329
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000177
GnomAD4 genome
AF:
0.000528
AC:
59
AN:
111687
Hom.:
0
Cov.:
23
AF XY:
0.000472
AC XY:
16
AN XY:
33931
show subpopulations
Gnomad4 AFR
AF:
0.00192
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000272
Hom.:
0
Bravo
AF:
0.000559
ESP6500AA
AF:
0.000548
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000885
AC:
10

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGeneDxMay 13, 2013p.Leu442Pro (CTG>CCG): c.1325 T>C in exon 11 of the SYN1 gene (NM_133499.2) The Leu442Pro missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. Although both Leucine and Proline are uncharged, non-polar amino acid residues, the gain of a Proline may affect the secondary structure of the synapsin-1 protein. Leu442Pro alters a position that is not well conserved in the protein and to our knowledge, other missense mutations have not been reported in this region of the protein. Several in-silico algorithms predict Leu442Pro may be benign, while another model suggests it may be damaging to the structure/function of the protein. Therefore, based on the currently available information, it is unclear whether Leu442Pro is a disease-causing mutation or a rare benign variant. The variant is found in EPILEPSY panel(s). -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 16, 2015- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsApr 11, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 07, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.77
Cadd
Benign
19
Dann
Benign
0.96
DEOGEN2
Benign
0.16
T;.;.
FATHMM_MKL
Benign
0.35
N
LIST_S2
Benign
0.39
T;T;D
M_CAP
Benign
0.028
D
MetaRNN
Benign
0.0097
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;N;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.65
N;N;.
REVEL
Benign
0.021
Sift
Benign
0.15
T;T;.
Sift4G
Benign
0.34
T;T;.
Polyphen
0.0
B;B;.
Vest4
0.16
MVP
0.21
MPC
1.1
ClinPred
0.034
T
GERP RS
1.4
Varity_R
0.16
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs375440874; hg19: chrX-47434155; API